There are further reports that higher levels of HIF-1α can be associated with hypoxia-mediated multi-drug resistance in patients undergoing chemotherapy via the inhibition of drug-induced apoptosis of laryngeal cancer cell, leading to a decrease in drug accumulation within tumour cells [21]. This evidence concerns the gene HIF1A and laryngeal carcinoma.